Health

Research has shown a potential link between disrupted circadian rhythms in cognitively normal adults and increased levels of amyloid-beta, a biomarker associated with Alzheimer’s disease. These findings shed light on the importance of healthy sleep patterns in reducing the risk of developing dementia. A study conducted by Julia Neitzel, PhD, and colleagues at Erasmus University

The recent expansion of the FDA indication for efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo) to include treatment for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) has been hailed as a groundbreaking development in the field. Dr. Jeffrey Allen from the University of Minnesota described the FDA’s decision as a significant milestone in the treatment of

Diabetes patients often struggle with the debilitating effects of diabetic retinopathy and maculopathy, leading to significant visual impairment. However, a recent study conducted by the University of Oxford has shed light on a potential solution to slow down the progression of early eye disease in diabetes patients. The LENS trial, led by David Preiss, MBChB,

The drug landscape is constantly evolving, presenting new challenges for healthcare professionals, law enforcement, and individuals who use drugs. The recent emergence of medetomidine, a veterinary sedative, in street drugs has raised significant concerns due to its potent effects and the challenges it poses in managing overdoses. What sets medetomidine apart from other substances is

Recent advancements in the field of oncology have brought about exciting new findings in the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR mutations. Dr. Roy Herbst of Yale Cancer Center in New Haven, Connecticut, sheds light on the promising results from the LAURA and ADAURA trials involving osimertinib (Tagrisso) and its

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that can lead to a range of complications, including lupus nephritis, chronic kidney disease (CKD), and cardiovascular events. Recent analysis of medical records has shown that individuals with SLE who are taking metformin may have lower rates of these complications compared to those who are not

Rheumatoid arthritis is a chronic autoimmune disease that not only affects the joints but also increases the risk of cardiovascular events and mortality. Previous studies have shown that conventional risk factors are not sufficient to predict major adverse cardiovascular events (MACE) and mortality in rheumatoid arthritis patients. Factors such as smoking, obesity, hypertension, and even

A recent study has shed light on the lost opportunities to provide adequate treatment for drug overdose survivors who are covered by the Medicare program. The study highlights the challenges in managing chronic pain among this vulnerable population. According to Dr. Brian Hurley, president of the American Society of Addiction Medicine, overdose survivors should have

The FDA recently approved two new immunotherapy-chemotherapy options for patients with primary advanced or recurrent endometrial cancer. The first option is the PD-1-directed immune checkpoint inhibitor pembrolizumab (Keytruda), which is approved in combination with carboplatin and paclitaxel for patients with either mismatch repair (MMR)-deficient or MMR-proficient disease. The approval was based on the promising results

Dean Ornish, MD, claims that the only side effects of an intensive lifestyle intervention for early Alzheimer’s disease are good ones. While this may sound promising, it is essential to critically analyze the validity of such a statement. Is it truly possible for any medical intervention to have only positive side effects, without any potential